Total Payments
$326.41
2023 Payments
$27.26
Companies
13
Transactions
21
Payment Breakdown by Category
Food & Beverage$326.41 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $326.41 | 21 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $61.48 | 4 | $0 (2019) |
| Daiichi Sankyo Inc. | $43.00 | 2 | $0 (2020) |
| Pharmacyclics LLC, An AbbVie Company | $36.41 | 3 | $0 (2019) |
| Clovis Oncology, Inc. | $29.74 | 2 | $0 (2018) |
| Boston Scientific Corporation | $27.26 | 1 | $0 (2023) |
| Celgene Corporation | $26.70 | 2 | $0 (2019) |
| Ipsen Biopharmaceuticals, Inc | $21.38 | 1 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $16.76 | 1 | $0 (2017) |
| Ethicon Inc. | $14.59 | 1 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $14.30 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $27.26 | 1 | Boston Scientific Corporation ($27.26) |
| 2022 | $14.59 | 1 | Ethicon Inc. ($14.59) |
| 2020 | $23.47 | 1 | Daiichi Sankyo Inc. ($23.47) |
| 2019 | $86.87 | 6 | AstraZeneca Pharmaceuticals LP ($33.56) |
| 2018 | $119.23 | 8 | Clovis Oncology, Inc. ($29.74) |
| 2017 | $54.99 | 4 | Novartis Pharmaceuticals Corporation ($16.76) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/22/2023 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $27.26 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 04/27/2022 | Ethicon Inc. | Monarch Platform (Device) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Endo-Mechanical | ||||||
| 03/02/2020 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: Anemia | ||||||
| 12/20/2019 | PFIZER INC. | IBRANCE (Drug), RETACRIT, NIVESTYM | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2019 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Oncology | ||||||
| 06/03/2019 | Celgene Corporation | Revlimid (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Hematology / Oncology | ||||||
| 05/28/2019 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $12.21 | General |
| Category: Oncology | ||||||
| 05/17/2019 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/13/2019 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/15/2018 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Oncology | ||||||
| 04/23/2018 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Anemia | ||||||
| 04/20/2018 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $12.22 | General |
| Category: Oncology | ||||||
| 03/13/2018 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $10.71 | General |
| Category: Oncology | ||||||
| 03/12/2018 | Celgene Corporation | Revlimid (Drug) | Food and Beverage | In-kind items and services | $11.35 | General |
| Category: Hematology / Oncology | ||||||
| 03/09/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/16/2018 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Oncology | ||||||
| 02/07/2018 | Ipsen Biopharmaceuticals, Inc | — | Food and Beverage | In-kind items and services | $21.38 | General |
| 08/10/2017 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Oncology | ||||||
| 03/06/2017 | Teva Pharmaceuticals USA, Inc. | BENDEKA (Drug) | Food and Beverage | In-kind items and services | $11.26 | General |
| Category: Oncology | ||||||
| 02/08/2017 | Novartis Pharmaceuticals Corporation | AFINITOR (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: ONCOLOGY | ||||||
| 01/31/2017 | Genentech USA, Inc. | Avastin (Biological) | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: BioOncology | ||||||
About Dr. Willard Andes, MD
Dr. Willard Andes, MD is a Medical Oncology healthcare provider based in Longview, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2007. The National Provider Identifier (NPI) number assigned to this provider is 1639215932.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Willard Andes, MD has received a total of $326.41 in payments from pharmaceutical and medical device companies, with $27.26 received in 2023. These payments were reported across 21 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($326.41).
Ad
Practice Information
- Specialty Medical Oncology
- Other Specialties Internal Medicine, Hematology
- Location Longview, WA
- Active Since 01/30/2007
- Last Updated 07/21/2020
- Taxonomy Code 207RX0202X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1639215932
Products in Payments
- IMFINZI (Drug) $45.78
- INJECTAFER (Drug) $43.00
- Imbruvica (Drug) $36.41
- Rubraca (Drug) $29.74
- WATCHMAN FLX (Device) $27.26
- Revlimid (Drug) $26.70
- AFINITOR (Drug) $16.76
- TAGRISSO (Drug) $15.70
- Monarch Platform (Device) $14.59
- XARELTO (Drug) $14.30
- IBRANCE (Drug) $12.26
- Avastin (Biological) $11.27
- BENDEKA (Drug) $11.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Oncology Doctors in Longview
Dr. Rama Koya, Md, MD
Medical Oncology — Payments: $7,038
Medical Oncology $7,038
Dr. Neeraj Sharma, Md, MD
Medical Oncology — Payments: $4,347
Medical Oncology $4,347
Dr. Larry Frase, M.d, M.D
Medical Oncology — Payments: $3,658
Medical Oncology $3,658
Dr. Lewis Duncan, M.d, M.D
Medical Oncology — Payments: $60.99
Medical Oncology $60.99